| (Values in U.S. Thousands) | Jun, 2023 | Mar, 2023 | Mar, 2022 | Dec, 2021 | Mar, 2022 |
| Sales | 1,120 | 20 | 1,610 | 7,460 | 1,610 |
| Sales Growth | +5,500.01% | -98.76% | -78.42% | +363.35% | -78.42% |
| Net Income | -17,830 | -15,300 | -22,650 | -68,080 | -22,650 |
| Net Income Growth | -16.54% | +32.45% | +66.73% | -200.57% | +66.73% |
Ambrx Biopharma Inc ADR (AMAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
Fiscal Year End Date: 12/31